Dan Sherbenou, MD, PhD

I have devoted my professional life to understanding what makes cells become cancerous and how to turn that knowledge into the best possible treatments. I seek to empower my patients with knowledge about their disease and its treatments. For me, it is a privilege to provide cancer care and I strive to help patients realize their best possible quality of life.

Specialties

Hematology ( 2012 )
Medical Oncology
Internal Medicine ( 2012 )

Conditions & Treatments

Cancers
Blood and Marrow Transplant, Leukemia (Adult Acute), Leukemia (Adult Chronic), Lymphoma, Myeloma

Interests & Activities

Personal Interests

As an undergraduate at the University of Colorado, I started my scientific career focused on basic science research of cancer. In the laboratory of Dr. Min Han, I studied the Ras cell signaling pathway using the C. elegans model organism. In the MD/PhD program at Oregon Health & Science University, I focused on translational leukemia research. Under the mentorship of Drs. Brian Druker and Michael Deininger, I studied chronic myeloid leukemia. My thesis evaluated mechanisms of kinase inhibitor resistance in patients treated with imatinib (Gleevec). In oncology fellowship at University of California at San Francisco, I focused on the study of antibody-based therapeutics under the mentorship of Dr. Bin Liu. Antibody-drug conjugates (ADCs) are another rapidly growing approach to cancer treatment. With Dr. Liu, I conducted preclinical analyses of a novel ADC for multiple myeloma, with hope for this to soon lead to transition to the clinic. Now a faculty member at UC Denver in the Hematology division, I oversee a translational research laboratory focused on novel therapy development and optimization for multiple myeloma and care for patients with myeloma and related plasma cell disorders from Colorado and adjoining areas. In my spare time, I enjoy spending time with my wife and 2 young sons. I love the mountains and spending time outdoors, hiking, road biking, mountain biking and rock climbing.

Education & Training

Medical Schools

MD, Oregon Health & Science University School of Medicine (2009)

Undergraduate Schools

BA, University of Colorado - Boulder (CO) (1999)

Graduate Schools

PhD, Oregon Health And Science University (2009)

Internships

University of Utah Medical Center Program (2010)

Residency Program

University of Utah Medical Center Program (2012)

Fellowships

University of California (San Francisco) Program (2015)

Professional Memberships

American Society of Clinical Oncology (ASCO), Member

American Society of Hematology (ASH), Member

Society for Immunotherapy of Cancer (SITC), Member

Research & Grants

Research Interests for Patients

My lab is located in the blood cancer and bone marrow transplant program of the hematology division of the University of Colorado Anschutz Medical campus. Our research focus is in therapeutic optimization for multiple myeloma, especially for patients with drug resistant and advanced disease. In particular, we are interested in helping develop and apply new immunotherapies to myeloma, especially antibody-based therapies.

information for referring providers

Referral Contact Phone

(720) 848-6400

Clinical Interests for Referring Providers

Multiple myeloma and related plasma cell disorders

Research Interest for Referring Providers

My lab is located in the blood cancer and bone marrow transplant program of the hematology division of the University of Colorado Anschutz Medical campus. Our research focus is in therapeutic optimization for multiple myeloma, especially or patients with drug resistant and advanced disease. In particular, we are interested in helping develop and apply new immunotherapies to myeloma, especially antibody-based therapies.

Find A Provider

Practice Locations

UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus